A GP practice's failure to urgently refer a patient with bladder cancer symptoms has been highlighted in a report by the Public Services ...

The Program Committee of the AUA has accepted the Theralase®'s abstract titled: ' Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive ...

TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the resear ...

Last year, a study highlighted that your doctor's office might be taking your blood pressure wrong. The current best practice ...

Innovative fluorescence-based diagnostic system identifies early-stage bladder cancer with 90% accuracy, utilizing untreated ...

Learn about urinary incontinence, its types, causes, and evidence-backed treatment strategies to regain control.

Listing is typically what happens when these air suspensions fail — with the passenger in the left rear seat, for instance, suddenly looking up at the passenger in the right front. This system ...

In bladder cancer, IBRX has worked to pursue approvals ... among the 86 patients (NSCLC with prior checkpoint inhibition failure) was 14.1 months. IBRX's recent rise in market valuation has ...

The most common immunotherapy for treating early-stage bladder cancer is the Bacillus Calmette-Guerin (BCG) vaccine treatment. If that fails, the only other alternative is surgery to remove the entire ...

The most common immunotherapy for treating early-stage bladder cancer is the Bacillus Calmette-Guerin (BCG) vaccine treatment. If that fails, the only other alternative is surgery to remove the ...

Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde ...